Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, placebo-controlled, parallel-group comparative study - Kadowaki, T; Inagaki, N; Kondo, K; Nishimura, K; Kaneko, G; Maruyama, N; Nakanishi, N; Gouda, M; Iijima, H; Watanabe, Y (Diabetes Obes Metab, 2018)